Natamycin Sales

Natamycin Sales Market Outlook

The global Natamycin market is projected to reach approximately USD 1.2 billion by 2035, growing at a compound annual growth rate (CAGR) of around 4.5% during the forecast period from 2025 to 2035. The growth of the Natamycin market is primarily driven by the rising demand for food preservation solutions and the growing awareness of food safety among consumers and manufacturers. Additionally, the increasing use of Natamycin as a natural antifungal agent in various applications such as food & beverage and pharmaceuticals is contributing to the market expansion. Furthermore, the trend towards clean-label products and the shift towards natural additives in the food industry are fueling the adoption of Natamycin. The pharmaceutical and agricultural sectors also constitute significant growth opportunities as they recognize the effectiveness of Natamycin in enhancing product shelf life and preventing spoilage.

Growth Factor of the Market

A multitude of factors contribute to the growth of the Natamycin market, making it a dynamic sector within the broader food additive and preservative industry. Firstly, the increasing consumer preference for natural preservatives over synthetic alternatives is pivotal, as consumers become more aware of the health implications of artificial additives. Furthermore, the expansion of the food processing industry, particularly in developing countries, is also creating a surge in demand for effective preservation methods. The expanding global population and the corresponding need for efficient food supply chains are emphasizing the necessity of using preservatives like Natamycin to extend shelf life and maintain product quality. Additionally, advancements in the formulation and delivery of Natamycin products are enhancing their efficacy, thus driving further market penetration. Lastly, regulatory approvals and endorsements for the use of Natamycin in various applications are boosting the confidence of manufacturers and end-users in employing this versatile compound.

Key Highlights of the Market

• The Natamycin market is poised for significant growth, primarily driven by the food preservation segment.
• Increasing consumer demand for natural and clean-label food products is propelling the market forward.
• Rising applications in pharmaceuticals and agriculture sectors are opening new avenues for market expansion.
• The market is expected to witness innovations in product formulations and delivery methods.
• Regulatory support and acceptance for Natamycin's safety profile enhance its market potential.

By Product Type

Liquid Natamycin:

Liquid Natamycin is a prominent form of this antifungal compound, known for its ease of application and effectiveness in various food products. This type is extensively used in the food and beverage industry, particularly for preserving dairy products, meat, and baked goods. The liquid formulation allows for uniform distribution and penetration into the product matrix, ensuring optimal antifungal activity. As more manufacturers seek efficient preservation techniques that cater to consumer preferences for minimally processed foods, the demand for liquid Natamycin is projected to rise. Furthermore, the versatility of liquid Natamycin in various applications enhances its appeal across multiple sectors, strengthening its market position.

Powder Natamycin:

Powder Natamycin is another widely utilized form of this compound, offering benefits such as longer shelf life and ease of storage. The powdered variant is particularly favored in applications where a dry form of preservatives is preferred, allowing for easy incorporation into different food matrices. It is often used in processed meats and cheeses, where it effectively inhibits mold and yeast growth. The global push towards cleaner labels and natural ingredients has augmented the market for powdered Natamycin, as it aligns with consumer expectations for transparency in food production. Manufacturers are increasingly incorporating powdered Natamycin into their products, thereby driving its growth in the market.

Natamycin Tablets:

Natamycin tablets serve as a convenient delivery form for therapeutic applications, particularly in the pharmaceutical sector. These tablets are formulated to treat various fungal infections, demonstrating the versatility of Natamycin beyond food preservation. The growing incidence of fungal infections globally has spurred the demand for effective antifungal treatments like Natamycin tablets. Furthermore, increased healthcare expenditure and the rising awareness of fungal infections among patients continue to boost the market for Natamycin tablets. The product's ease of use and targeted action make it an attractive option for both healthcare providers and patients, thereby contributing to its growth.

Natamycin Capsules:

Similar to tablets, Natamycin capsules represent another essential formulation in the pharmaceutical application of this compound. Capsules offer distinct advantages, including improved bioavailability and the ability to mask unpleasant tastes associated with certain active ingredients. The use of Natamycin in capsule form is particularly favored for systemic antifungal therapy, allowing for precise dosing and patient compliance. The rising prevalence of fungal infections and the growing inclination towards capsule formulations among consumers augment the demand for Natamycin capsules in the pharmaceutical landscape. This segment is expected to continue its upward trajectory as healthcare providers seek effective and patient-friendly antifungal options.

Natamycin Creams:

Natamycin creams are gaining traction in the skincare and pharmaceutical sectors, offering antifungal properties for topical applications. These creams are utilized in treating various skin infections caused by fungi, providing targeted action while being gentle on the skin. The increasing prevalence of dermatological conditions, coupled with the rising consumer awareness regarding skin health, has propelled the demand for Natamycin creams. Additionally, the trend toward natural and effective topical formulations aligns well with the properties of Natamycin, making it an attractive choice for manufacturers. As the skincare market continues to grow, the inclusion of Natamycin in topical formulations is expected to expand significantly.

By Application

Food & Beverage:

The food and beverage sector is the largest application area for Natamycin, primarily due to its effectiveness as a natural preservative. It is widely used to inhibit the growth of molds and yeasts in various food items, including dairy products, cured meats, and baked goods. The increasing consumer demand for longer shelf-life products without the use of synthetic preservatives has further propelled the adoption of Natamycin in this sector. As food safety regulations become stricter and consumers become more health-conscious, the importance of natural preservatives like Natamycin is amplified, positioning this segment for continuous growth in the coming years.

Pharmaceutical:

In the pharmaceutical industry, Natamycin serves as a potent antifungal agent, with applications in treating various fungal infections. The rise in the incidence of such infections, particularly in immunocompromised individuals, has led to a growing demand for effective antifungal treatments. Natamycin’s safety profile and efficacy make it a preferred choice among healthcare providers for topical and systemic antifungal therapies. As research continues to unveil the potential of Natamycin in addressing fungal infections, this application segment is poised to experience significant growth, further supported by increasing healthcare spending worldwide.

Animal Feed:

Natamycin is also utilized in the animal feed industry, where it acts as a natural preservative to prevent fungal contamination in feed products. The growing awareness of animal health and the need for high-quality feed products have led to an increase in the incorporation of Natamycin in animal nutrition. This application not only helps in preserving the nutritional value of the feed but also promotes the overall health and productivity of livestock. As the livestock and poultry industries expand globally, the demand for antifungal agents like Natamycin in animal feed is expected to witness substantial growth, supporting the market's upward trajectory.

Agriculture:

In the agricultural sector, Natamycin is recognized for its antifungal properties, helping to protect crops from fungal infections. The increasing focus on sustainable agricultural practices and the need to minimize chemical pesticide use have led to a rise in the adoption of natural fungicides like Natamycin. Farmers are increasingly inclined to use bio-based solutions to enhance crop yield and quality, and Natamycin fits this demand perfectly. The growth of organic farming and the rising emphasis on environmentally friendly pest control methods are expected to further drive the application of Natamycin in agriculture, enhancing its significance in the overall market.

Others:

The 'Others' segment encompasses various applications of Natamycin not classified under the primary categories. This includes uses in cosmetics, personal care products, and household items where antifungal properties are required. The expansion of the cosmetics market and the growing emphasis on skin health have created opportunities for Natamycin as a natural preservative and antifungal agent in skincare formulations. As consumer preferences shift towards natural and clean products across various domains, the presence of Natamycin in diverse applications is anticipated to grow, broadening its market reach.

By Distribution Channel

Online Stores:

The rise of e-commerce has transformed the distribution landscape for Natamycin, with online stores becoming a significant channel for purchasing products. Consumers and businesses alike are increasingly turning to online platforms for convenience, accessibility, and a wider range of options. This shift towards online shopping is particularly pronounced in the pharmaceutical sector, where patients seek easy access to antifungal treatments. Additionally, the food and beverage industry benefits from online distribution, allowing manufacturers to reach a broader audience. As online retail continues to expand, the distribution of Natamycin through this channel is expected to grow substantially.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets remain vital distribution channels for Natamycin, especially in the food and beverage sector. These retail establishments offer consumers the opportunity to purchase food products containing Natamycin directly from a physical location, ensuring convenience and consumer trust. The broad selection of food items available in these stores, coupled with the increasing consumer awareness of food safety, has led to a steady demand for products preserved with natural additives like Natamycin. As the food retail landscape evolves, supermarkets and hypermarkets are expected to continue playing a crucial role in the distribution of Natamycin-containing products.

Specialty Stores:

Specialty stores, often focused on health and wellness products, are becoming an essential distribution channel for Natamycin, particularly in the pharmaceutical and natural products sectors. These stores cater to consumers seeking specific health solutions, including antifungal treatments and natural food preservatives. The growing trend towards holistic health and wellness has driven consumer traffic to specialty stores, enhancing the visibility and availability of Natamycin-based products. As the health-conscious consumer base expands, specialty stores are expected to play an increasingly prominent role in promoting Natamycin and its applications.

Others:

The 'Others' category includes distribution channels such as pharmacies and direct sales that are crucial for the accessibility of Natamycin products, particularly in the pharmaceutical sector. Pharmacies provide an essential service by offering antifungal treatments, ensuring that patients have access to effective medications. Direct sales, including business-to-business transactions, also contribute to the distribution of Natamycin products in various industries. As the market evolves, these alternative distribution channels will continue to be significant in meeting the diverse needs of consumers and businesses alike.

By Ingredient Type

Natamycin 50%:

Natamycin 50% is a widely used formulation known for its effectiveness in various applications, especially in the food and beverage sector. This concentration is particularly beneficial in applications requiring a moderate antifungal effect, providing a balance between efficacy and cost. The increasing demand for shelf-stable food products has driven the utilization of Natamycin 50%, as manufacturers seek affordable solutions to extend product longevity. This formulation has gained traction in food preservation due to its ability to inhibit spoilage organisms effectively, thereby enhancing the overall market for Natamycin.

Natamycin 95%:

Natamycin 95% is favored for applications demanding higher antifungal efficacy, especially in pharmaceutical formulations. This concentration is particularly effective in treating fungal infections, making it a preferred choice for healthcare providers. The growing incidence of such infections necessitates the use of potent antifungal agents, positioning Natamycin 95% as a critical player in the pharmaceutical market. As healthcare systems continue to prioritize effective treatments, the demand for this concentration is expected to rise significantly, contributing to the overall growth of the Natamycin market.

Natamycin 98%:

Natamycin 98% represents one of the highest concentrations available, primarily used in specialized applications where maximum antifungal effectiveness is required. This formulation is commonly utilized in advanced pharmaceutical applications and specialized food preservation techniques. The need for high-potency solutions in both healthcare and food sectors supports the growing demand for Natamycin 98%, particularly as the global focus on health and safety intensifies. This segment is expected to witness substantial growth, underpinned by innovations in formulation and application techniques.

Natamycin 99%:

Natamycin 99% is the purest form available and is typically reserved for niche applications requiring the highest level of antifungal efficacy. This concentration is often employed in research and development settings, where its potent properties are harnessed to explore new formulations and therapeutic uses. The increasing focus on research in antifungal treatments and the growing need for highly effective preservatives contribute to the demand for Natamycin 99%. As the market for specialized applications expands, this segment is expected to see notable growth, supported by advancements in scientific research.

Others:

The 'Others' category encompasses various formulations of Natamycin not classified under the primary concentration types. This may include customized formulations designed for specific applications or blends with other preservatives to enhance effectiveness. The diverse needs of the food, pharmaceutical, and agricultural sectors drive the development of these novel formulations, allowing manufacturers to cater to a broader range of applications. As the market evolves, the demand for innovative and specialized products will continue to support growth in this segment.

By Region

The North American market for Natamycin is expected to witness steady growth, attributed to the increasing demand for natural preservatives in the food and beverage industry. The growing consumer preference for clean-label products has influenced food manufacturers to seek out effective natural additives like Natamycin. The region is projected to grow at a CAGR of approximately 4.2% during the forecast period, driven by stringent food safety regulations and the ongoing trend towards health-conscious eating habits. The United States, being a significant player in the food processing sector, remains a key contributor to the overall North American market.

In Europe, the Natamycin market is anticipated to expand significantly, bolstered by the increasing awareness of food safety and quality. The region’s strict food regulations promote the use of natural preservatives, further enhancing the demand for Natamycin. The European market is expected to grow at a CAGR of around 4.8% from 2025 to 2035, with countries like Germany and France leading the charge. The presence of a robust pharmaceutical sector in Europe also supports the growth of Natamycin in therapeutic applications. As the region continues to prioritize sustainability and health, Natamycin's market presence is poised for substantial growth.

Opportunities

The Natamycin market is ripe with opportunities, particularly as consumer preferences shift towards natural and clean-label products. The growing awareness about food safety and the health implications of synthetic preservatives has led to an increased focus on natural alternatives. As consumers demand transparency in food production, manufacturers are increasingly looking to incorporate ingredients like Natamycin in their formulations. This presents a significant opportunity for companies to innovate and develop new products that align with consumer trends, thereby enhancing their market presence. Moreover, the expansion of the food processing industry in developing regions signifies substantial growth potential for Natamycin, as these markets embrace modern preservation techniques to meet the needs of an expanding population.

Additionally, the rise in the pharmaceutical sector's interest in Natamycin as an antifungal agent opens new avenues for market growth. With the incidence of fungal infections on the rise, there is a pressing need for effective treatment options. Companies focusing on research and development of Natamycin-based pharmaceuticals can capitalize on this demand, leading to increased market penetration. Furthermore, the agricultural sector's growing recognition of Natamycin's effectiveness as a natural fungicide adds another layer of opportunity, particularly as sustainable farming practices become more prevalent. By leveraging these opportunities across various sectors, stakeholders in the Natamycin market can secure a competitive advantage and drive sustainable growth.

Threats

While the Natamycin market presents numerous opportunities, it is not without its challenges. One of the primary threats is the increasing competition from synthetic preservatives, which often offer lower production costs and higher efficacy. Manufacturers may be tempted to opt for these alternatives in a bid to reduce costs, which could hinder the growth of the Natamycin market. Furthermore, fluctuations in raw material prices may adversely affect production costs, impacting the pricing strategy for Natamycin products. These challenges necessitate that stakeholders focus on differentiating their offerings and highlighting the benefits of natural preservatives to mitigate the threat posed by cheaper synthetic alternatives.

Another significant concern is the regulatory landscape surrounding food additives and preservatives. As governments around the world tighten regulations regarding food safety and additives, companies must navigate complex compliance requirements. Failure to adhere to these regulations could result in substantial financial penalties and damage to brand reputation. Additionally, the potential for adverse reactions among some consumer groups to certain formulations may restrict market acceptance. Companies need to invest in thorough research and development to ensure safety and efficacy while keeping an eye out for changes in regulatory standards to mitigate these threats effectively. Continuous monitoring of market dynamics and consumer preferences will be vital in overcoming these challenges.

Competitor Outlook

• DSM Food Specialties
• Kemin Industries, Inc.
• Merck KGaA
• Wacker Chemie AG
• Naturalin Bio-Resources Co., Ltd.
• FMC Corporation
• Ginkgo BioWorks, Inc.
• Pantheryx, Inc.
• Hawkins Watts Limited
• Givaudan SA
• Hochdorf Swiss Nutrition AG
• Hapilabs
• Advanced BioNutrition Corp.
• BASF SE
• Biocon Limited

The competitive landscape of the Natamycin market is characterized by a diverse range of players actively engaged in the production and distribution of this natural antifungal agent. Key companies such as DSM Food Specialties and Kemin Industries are at the forefront, leveraging their extensive research and development capabilities to innovate and enhance the efficacy of Natamycin formulations. This focus on innovation is critical in a market that is increasingly leaning towards natural solutions for food preservation and health. Other established players like Merck KGaA and Wacker Chemie AG are also investing significantly in expanding their product portfolios to cater to the growing demand across various applications, including food, pharmaceuticals, and agriculture.

Furthermore, the emergence of smaller bio-tech firms, such as Ginkgo BioWorks, is reshaping the competitive dynamics of the Natamycin market. These companies are utilizing advanced biotechnological methods to produce Natamycin more efficiently, thus driving down production costs while maintaining product quality. Additionally, partnerships and collaborations among industry players are becoming increasingly common, as companies look to combine expertise and resources to expand their market reach. For instance, collaborations between agricultural and pharmaceutical companies are allowing for the exploration of new applications for Natamycin, thereby enhancing its utility across various sectors.

Furthermore, major companies like BASF SE and Biocon Limited are recognizing the growing significance of sustainability in consumer choices. They are investing in sustainable production processes and cleaner formulations, which resonate well with the health-conscious consumer base. Additionally, the focus on regulatory compliance and consumer safety is prompting companies to invest in rigorous testing and quality assurance protocols, ensuring that their Natamycin products meet the highest standards. As the market evolves, these competitive strategies will be crucial in positioning companies favorably within the Natamycin landscape, enabling them to capitalize on emerging opportunities while navigating the challenges of the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hapilabs
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Givaudan SA
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Biocon Limited
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 FMC Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Pantheryx, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Wacker Chemie AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 DSM Food Specialties
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Ginkgo BioWorks, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hawkins Watts Limited
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kemin Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Advanced BioNutrition Corp.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hochdorf Swiss Nutrition AG
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Naturalin Bio-Resources Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Natamycin Sales Market, By Application
    • 6.1.1 Food & Beverage
    • 6.1.2 Pharmaceutical
    • 6.1.3 Animal Feed
    • 6.1.4 Agriculture
    • 6.1.5 Others
  • 6.2 Natamycin Sales Market, By Product Type
    • 6.2.1 Liquid Natamycin
    • 6.2.2 Powder Natamycin
    • 6.2.3 Natamycin Tablets
    • 6.2.4 Natamycin Capsules
    • 6.2.5 Natamycin Creams
  • 6.3 Natamycin Sales Market, By Ingredient Type
    • 6.3.1 Natamycin 50%
    • 6.3.2 Natamycin 95%
    • 6.3.3 Natamycin 98%
    • 6.3.4 Natamycin 99%
    • 6.3.5 Others
  • 6.4 Natamycin Sales Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Supermarkets/Hypermarkets
    • 6.4.3 Specialty Stores
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Natamycin Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Natamycin Sales market is categorized based on

By Product Type

• Liquid Natamycin
• Powder Natamycin
• Natamycin Tablets
• Natamycin Capsules
• Natamycin Creams

By Application

• Food & Beverage
• Pharmaceutical
• Animal Feed
• Agriculture
• Others

By Distribution Channel

• Online Stores
• Supermarkets/Hypermarkets
• Specialty Stores
• Others

By Ingredient Type

• Natamycin 50%
• Natamycin 95%
• Natamycin 98%
• Natamycin 99%
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• DSM Food Specialties
• Kemin Industries, Inc.
• Merck KGaA
• Wacker Chemie AG
• Naturalin Bio-Resources Co., Ltd.
• FMC Corporation
• Ginkgo BioWorks, Inc.
• Pantheryx, Inc.
• Hawkins Watts Limited
• Givaudan SA
• Hochdorf Swiss Nutrition AG
• Hapilabs
• Advanced BioNutrition Corp.
• BASF SE
• Biocon Limited